Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter W Lewis

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cancer Cell|September 19, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.
Cancer Discovery|September 24, 2020
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of BoneSima Khazaei, Nicolas De Jay, Shriya Deshmukh, et al.
Cell|March 10, 2010
Distinct factors control histone variant H3.3 localization at specific genomic regionsAaron D Goldberg, Laura A Banaszynski, Kyung-Min Noh, et al.
Nature Communications|March 21, 2019
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesisAshot S Harutyunyan, Brian Krug, Haifen Chen, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cancer Cell|September 19, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Science (New York, N.Y.)|May 14, 2016
Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscapeChao Lu, Siddhant U Jain, Dominik Hoelper, et al.
Cancer Discovery|September 24, 2020
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of BoneSima Khazaei, Nicolas De Jay, Shriya Deshmukh, et al.
Cell|March 10, 2010
Distinct factors control histone variant H3.3 localization at specific genomic regionsAaron D Goldberg, Laura A Banaszynski, Kyung-Min Noh, et al.
Nature Communications|March 21, 2019
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesisAshot S Harutyunyan, Brian Krug, Haifen Chen, et al.
Science Translational Medicine|July 20, 2022
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcomaShivendra Singh, Ahmed Abu-Zaid, Hongjian Jin, et al.
Pageof 6